Ruixian Liu

1.2k total citations
23 papers, 875 citations indexed

About

Ruixian Liu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ruixian Liu has authored 23 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Ruixian Liu's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). Ruixian Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (5 papers). Ruixian Liu collaborates with scholars based in China, United States and France. Ruixian Liu's co-authors include Fang‐Zhu Ouyang, Christos Xiao, Xiang‐Ming Lao, Dong‐Ming Kuang, Limin Zheng, Wei Yuan, Minmin Chen, Dong‐Ping Chen, Ka‐Wo Chan and Xiaoyu Zhao and has published in prestigious journals such as Physical Review Letters, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Ruixian Liu

22 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruixian Liu China 10 453 383 285 191 82 23 875
Xiaowen Mao Hong Kong 17 188 0.4× 121 0.3× 416 1.5× 251 1.3× 95 1.2× 27 892
Huaichao Luo China 13 116 0.3× 132 0.3× 305 1.1× 190 1.0× 56 0.7× 58 619
Michiko Harao Japan 16 377 0.8× 329 0.9× 362 1.3× 132 0.7× 88 1.1× 36 915
Robyn D. Gartrell United States 18 297 0.7× 472 1.2× 221 0.8× 90 0.5× 118 1.4× 45 842
Saumil Gandhi United States 16 139 0.3× 358 0.9× 259 0.9× 93 0.5× 333 4.1× 55 1.0k
S. Heinrich Germany 8 186 0.4× 200 0.5× 268 0.9× 201 1.1× 100 1.2× 12 576
Shih‐Yu Chen Taiwan 14 280 0.6× 183 0.5× 484 1.7× 98 0.5× 125 1.5× 29 973
Daniel Schmolze United States 15 160 0.4× 254 0.7× 278 1.0× 136 0.7× 89 1.1× 41 791
Zipei Feng United States 14 516 1.1× 692 1.8× 276 1.0× 93 0.5× 91 1.1× 36 1.0k
Sunandana Chandra United States 16 334 0.7× 817 2.1× 424 1.5× 122 0.6× 206 2.5× 49 1.2k

Countries citing papers authored by Ruixian Liu

Since Specialization
Citations

This map shows the geographic impact of Ruixian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixian Liu more than expected).

Fields of papers citing papers by Ruixian Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixian Liu. The network helps show where Ruixian Liu may publish in the future.

Co-authorship network of co-authors of Ruixian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixian Liu. A scholar is included among the top collaborators of Ruixian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixian Liu. Ruixian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhe, Yimeng Xia, Zhihong Wang, et al.. (2025). Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity. Frontiers in Immunology. 16. 1500417–1500417. 1 indexed citations
2.
Liu, Ruixian & Peter Gerstoft. (2024). Spatial acoustic properties recovery with deep learning. The Journal of the Acoustical Society of America. 155(6). 3690–3701. 2 indexed citations
3.
Liu, Ruixian, et al.. (2024). Cryogenic Digital Image Correlation as a Probe of Strain in Iron-Based Superconductors. Chinese Physics Letters. 41(10). 107102–107102. 1 indexed citations
4.
Liu, Ruixian, Wenliang Zhang, Wei Yuan, et al.. (2024). Nematic Spin Correlations Pervading the Phase Diagram of FeSe1xSx. Physical Review Letters. 132(1). 16501–16501. 7 indexed citations
5.
Liu, Ruixian, et al.. (2024). Low-Energy Spin Excitations in Detwinned FeSe. Chinese Physics Letters. 41(6). 67401–67401.
6.
Liu, Ruixian, Chuangyu Wen, Wei‐Biao Ye, et al.. (2023). Altered B cell immunoglobulin signature exhibits potential diagnostic values in human colorectal cancer. iScience. 26(3). 106140–106140. 6 indexed citations
7.
Liu, Ruixian & Peter Gerstoft. (2023). SD-PINN: Physics Informed Neural Networks for Spatially Dependent PDES. 1–5. 6 indexed citations
8.
Zhang, Yuting, et al.. (2022). Computational Analysis of Pathological Image Enables Interpretable Prediction for Microsatellite Instability. Frontiers in Oncology. 12. 825353–825353. 7 indexed citations
9.
Lu, Xingye, Wenliang Zhang, Yi Tseng, et al.. (2022). Spin-excitation anisotropy in the nematic state of detwinned FeSe. Nature Physics. 18(7). 806–812. 20 indexed citations
10.
Chen, Junxiong, Xiangling Yang, Ruixian Liu, et al.. (2020). Circular RNA GLIS2 promotes colorectal cancer cell motility via activation of the NF-κB pathway. Cell Death and Disease. 11(9). 788–788. 41 indexed citations
11.
Wang, Huihui, Chuangyu Wen, Siyu Chen, et al.. (2020). Toosendanin-induced apoptosis in colorectal cancer cells is associated with the κ-opioid receptor/β-catenin signaling axis. Biochemical Pharmacology. 177. 114014–114014. 26 indexed citations
12.
Zhang, Qian, Ruixian Liu, Ka‐Wo Chan, et al.. (2019). Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells. Journal of Experimental & Clinical Cancer Research. 38(1). 320–320. 96 indexed citations
13.
Liu, Ruixian, Xiangling Yang, Weiqian Li, et al.. (2019). miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer. Journal for ImmunoTherapy of Cancer. 7(1). 210–210. 84 indexed citations
14.
Liu, Ruixian, Michael J. Bianco, & Peter Gerstoft. (2019). Wave Equation Extraction from A Video Using Sparse Modeling. 2160–2165. 5 indexed citations
15.
Chen, Minmin, Christos Xiao, Xiang‐Ming Lao, et al.. (2016). Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization. Cancer Discovery. 6(10). 1182–1195. 64 indexed citations
16.
Xiao, Christos, Xiang‐Ming Lao, Minmin Chen, et al.. (2016). PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Cancer Discovery. 6(5). 546–559. 268 indexed citations
17.
Ouyang, Fang‐Zhu, Ruiqi Wu, Wei Yuan, et al.. (2016). Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma. Nature Communications. 7(1). 13453–13453. 77 indexed citations
19.
Kuang, Dong‐Ming, Christos Xiao, Qiyi Zhao, et al.. (2014). B7-H1–expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets. Journal of Clinical Investigation. 124(10). 4657–4667. 68 indexed citations
20.
Liu, Ruixian, et al.. (2011). An approach to manage over-constrained mechatronic system in teamwork. 983–988. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026